<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Fecal microbiota rectal suspension: Drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Fecal microbiota rectal suspension: Drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Fecal microbiota rectal suspension: Drug information</div><div class="clear"></div><div id="topicText">(For additional information <a class="drug drug_patient" data-topicid="140407" href="/d/html/140407.html" rel="external">see "Fecal microbiota rectal suspension: Patient drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
<div class="list ubnlist drugH1Div drugBrandNames" id="F57865882"><span class="drugH1">Brand Names: US</span>
<ul>
<li>Rebyota</li></ul></div>
<div class="ex_sect_xr thclist drugH1Div drugBrandNames" id="F57601450"><span class="drugH1">Pharmacologic Category</span>
<ul>
<li>
                        Microbiota</li></ul></div>
<div class="block doa drugH1Div" id="F57633035"><span class="drugH1">Dosing: Adult</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="5aea94f0-cdab-48d8-a2fa-64de68a2cca2">
<i>Clostridioides difficile</i> infection, prophylaxis</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Clostridioides difficile</i> infection, prophylaxis: Rectal:</b> 150 mL (contents of 1 bag) as a single dose, administered 24 to 72 hours after completion of <i>C. difficile</i> treatment regimen (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-36287379']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-36287379'])">Ref</a></span>).</p></div>
</div>
</div>
<div class="block dora drugH1Div" id="F57633037"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling; however, not expected to be systemically absorbed.</p></div>
<div class="block doha drugH1Div" id="F57633038"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling; however, not expected to be systemically absorbed.</p></div>
<div class="block doe drugH1Div" id="F57633036"><span class="drugH1">Dosing: Older Adult</span>
<p style="text-indent:0em;display:inline">Refer to adult dosing.</p></div>
<div class="block adr drugH1Div" id="F57607489"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified. Adverse reactions reported in adults.</p>
<p style="text-indent:-2em;margin-left:2em;">1% to 10%: Gastrointestinal: Abdominal distention (4%), abdominal pain (9%), diarrhea (7%), flatulence (3%), nausea (3%)</p></div>
<div class="block coi drugH1Div" id="F57599835"><span class="drugH1">Contraindications</span>
<p style="text-indent:0em;display:inline">Severe hypersensitivity (eg, anaphylaxis) to fecal microbiota (live) or any component of the formulation.</p></div>
<div class="block war drugH1Div" id="F57633025"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<i>
<b>Concerns related to adverse effects:</b></i></p>
<p style="text-indent:-2em;margin-left:4em;">• Hypersensitivity reactions: Ensure appropriate medical treatment is readily available in the event an acute anaphylactic reaction occurs following administration.</p>
<p style="text-indent:-2em;margin-left:2em;">
<i>
<b>Dosage form specific issues:</b></i></p>
<p style="text-indent:-2em;margin-left:4em;">• Food allergies: Because product is manufactured from human fecal matter, may contain food allergens; however, potential for the product to cause adverse reactions due to food allergens is unknown.</p>
<p style="text-indent:-2em;margin-left:4em;">• Transmissible infectious agents: Manufactured from human fecal matter; may carry risk of transmitting infectious agents. Infections thought to be transmitted by this product should be reported to the manufacturer.</p></div>
<div class="block foc drugH1Div" id="F57865883"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Suspension, Rectal: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Rebyota: Fecal microbiota, live-jslm 150 mL (150 mL) [contains polyethylene glycol (macrogol)]</p></div>
<div class="block geq drugH1Div" id="F57865881"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">No</p></div>
<div class="block fee drugH1Div" id="F57892222"><span class="drugH1">Pricing: US</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Suspension</b> (Rebyota Rectal)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">150 mL (per mL): $72.00</p>
<p style="text-indent:0em;">
<b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>
<div class="block adm drugH1Div" id="F57633039"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:0em;display:inline">
<b>Rectal:</b> Prior to use, thaw completely by placing carton in refrigerator (2°C to 8°C [36°F to 46°F]) for ~24 hours; do <b>not</b> thaw using a heat source (eg, microwave, hot water). Administer via gravity flow using provided administration set; refer to manufacturer's product labeling for more information. Do not allow administration tube to sag or loop (may prevent entire dose from being delivered), do not squeeze the bag to deliver product (may cause patient discomfort), and do not hang bag from an IV stand. Some product will remain in tube after administration is complete. Dispose of all components in medical waste.</p></div>
<div class="block use drugH1Div" id="F57599834"><span class="drugH1">Use: Labeled Indications</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Clostridioides difficile</i> infection, prophylaxis:</b> Prevention of recurrence of <i>C. difficile</i> infection (CDI) in patients ≥18 years of age following antibiotic treatment of recurrent CDI.</p>
<p style="text-indent:-2em;margin-left:2em;">Limitations of use: Not indicated for treatment of CDI.</p></div>
<div class="block cyt drugH1Div" id="F57635130"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">None known.</p></div>
<div class="block dri drugH1Div" id="F57635127"><span class="drugH1">Drug Interactions</span><br/><br/><div class="clear"></div><p xmlns=""></p><div class="inner" xmlns=""><p style="text-indent:0em;display:inline"><b>Note</b>: Interacting drugs may <b>not be individually listed below</b> if they are part of a group interaction (eg, individual drugs within “CYP3A4 Inducers [Strong]” are NOT listed).  For a complete list of drug interactions by individual drug name and detailed management recommendations, use the Lexicomp drug interactions program by clicking on the “Launch drug interactions program” link above.</p><p xmlns=""></p></div>
<p style="text-indent:-2em;margin-left:2em;">Antibiotics: May diminish the therapeutic effect of Fecal Microbiota (Live) (Rectal).<i> Risk X: Avoid combination</i></p></div>
<div class="block pri drugH1Div" id="F57633023"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;display:inline">Rectal administration is not expected to have systemic absorption; fetal exposure is not expected following maternal administration.</p></div>
<div class="block brc drugH1Div" id="F57633024"><span class="drugH1">Breastfeeding Considerations</span>
<p style="text-indent:0em;display:inline">Rectal administration is not expected to have systemic absorption; exposure via breast milk is not expected following maternal administration.</p></div>
<div class="block pha drugH1Div" id="F57633034"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:0em;display:inline">Restoration of intestinal eubiosis (Soveral 2022).</p></div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference" id="lexi-content-ref-36287379">
<a name="36287379"></a>Khanna S, Assi M, Lee C, et al. Efficacy and safety of RBX2660 in PUNCH CD3, a phase III, randomized, double-blind, placebo-controlled trial with a Bayesian primary analysis for the prevention of recurrent Clostridioides difficile infection. <i>Drugs</i>. 2022;82(15):1527-1538. doi:10.1007/s40265-022-01797-x<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/fecal-microbiota-rectal-suspension-drug-information/abstract-text/36287379/pubmed" id="36287379" target="_blank">36287379</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Rebyota (fecal microbiota) [prescribing information]. Roseville, MN: Ferring Pharmaceuticals; November 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-36156924">
<a name="36156924"></a>Soveral LF, Korczaguin GG, Schmidt PS, Nunes IS, Fernandes C, Zárate-Bladés CR. Immunological mechanisms of fecal microbiota transplantation in recurrent Clostridioides difficile infection. <i>World J Gastroenterol</i>. 2022;28(33):4762-4772. doi:10.3748/wjg.v28.i33.4762<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/fecal-microbiota-rectal-suspension-drug-information/abstract-text/36156924/pubmed" id="36156924" target="_blank">36156924</a>]</span>
</div>
</li></ol></div><div id="topicVersionRevision">Topic 140384 Version 18.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
